title: Clinical trials in India.
abstract: The concept of outsourcing for the development and global studies on new drugs has become widely accepted in the pharmaceutical industry due to its cost and uncertainty. India is going to be the most preferred location for contract pharma research and development due to its huge treatment naïve population, human resources, technical skills, adoption/amendment/implementation of rules/laws by regulatory authorities, and changing economic environment. But still 'miles to go' to fulfill the pre-requisites to ensure India's success. In spite of all the pitfalls, the country is ambitious and optimist to attract multinational pharmaceutical companies to conduct their clinical trials in India.
authors: Department of Pharmacology, Prathima Institute of Medical Sciences, Nagunur Road, Karimnagar-505417, Andhra Pradesh, India. rituparnamaiti@rediffmail.com
authors: Rituparna
authors: R
authors: Maiti
authors: Raghavendra
authors: R
authors: M
mesh_terms: D002986:Clinical Trials as Topic / Q000191:economics* / Q000941:ethics / Q000639:trends; D017277:Drug Approval / Q000331:legislation & jurisprudence / Q000458:organization & administration; D004345:Drug Industry / Q000191:economics / Q000458:organization & administration / Q000639:trends; D006801:Humans; D007194:India; D018973:Intellectual Property; D038622:Internationality; D020416:Outsourced Services / Q000191:economics* / Q000941:ethics / Q000639:trends; D000078329:Workforce